Activation	O
of	O
the	O
Janus	B-protein
kinase	I-protein
3	I-protein
-STAT5a	B-protein
pathway	O
after	O
CD40	B-protein
triggering	O
of	O
human	B-cell_type
monocytes	I-cell_type
but	O
not	O
of	O
resting	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

CD40	B-protein
/CD40	B-protein
ligand	O
interactions	O
play	O
a	O
key	O
role	O
in	O
the	O
immune	O
responses	O
of	O
B	B-cell_type
lymphocytes	I-cell_type
,	O
monocytes	B-cell_type
,	O
and	O
dendritic	B-cell_type
cells	I-cell_type
.	O

The	O
signal	O
transduction	O
events	O
triggered	O
by	O
cross-linking	O
of	O
the	O
CD40	B-protein
receptor	I-protein
have	O
been	O
widely	O
studied	O
in	O
B	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
but	O
little	O
is	O
known	O
about	O
signaling	O
following	O
CD40	B-protein
stimulation	O
of	O
monocytes	B-cell_type
and	O
resting	B-cell_line
tonsillar	I-cell_line
B	I-cell_line
cells	I-cell_line
.	O

Therefore	O
,	O
we	O
studied	O
the	O
CD40	B-protein
pathway	O
in	O
highly	O
purified	O
human	B-cell_type
monocytes	I-cell_type
and	O
resting	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

After	O
CD40	B-protein
triggering	O
,	O
a	O
similar	O
activation	O
of	O
the	O
NF-kappaB	B-protein
(	O
but	O
not	O
of	O
the	O
AP-1	B-protein
)	O
transcription	B-protein
factor	I-protein
complex	I-protein
occurred	O
in	O
both	O
cell	O
preparations	O
.	O

However	O
,	O
the	O
components	O
of	O
the	O
NF-kappaB	B-protein
complexes	I-protein
were	O
different	O
in	O
monocytes	B-cell_type
and	O
B	O
cells	O
,	O
because	O
p50	B-protein
is	O
part	O
of	O
the	O
NF-kappaB	B-protein
complex	I-protein
induced	O
by	O
CD40	B-protein
triggering	O
in	O
both	O
monocytes	B-cell_type
and	O
B	B-cell_type
cells	I-cell_type
,	O
whereas	O
p65	B-protein
was	O
only	O
induced	O
in	O
B	B-cell_type
cells	I-cell_type
.	O
In	O
contrast	O
,	O
although	O
the	O
Janus	B-protein
kinase	I-protein
3	I-protein
tyrosine	I-protein
kinase	I-protein
was	O
associated	O
with	O
CD40	B-protein
molecules	O
in	O
both	O
monocytes	B-cell_type
and	O
resting	B-cell_type
B	I-cell_type
cells	I-cell_type
,	O
Janus	B-protein
kinase	I-protein
3	I-protein
phosphorylation	O
induction	O
was	O
observed	O
only	O
in	O
CD40-activated	B-cell_line
monocytes	I-cell_line
,	O
with	O
subsequent	O
induction	O
of	O
STAT5a	B-protein
DNA	O
binding	O
activity	O
in	O
the	O
nucleus	O
.	O

These	O
results	O
suggest	O
that	O
the	O
activation	O
signals	O
in	O
human	B-cell_type
B	I-cell_type
cells	I-cell_type
and	O
monocytes	B-cell_type
differ	O
following	O
CD40	B-protein
stimulation	O
.	O

This	O
observation	O
is	O
consistent	O
with	O
the	O
detection	O
of	O
normal	O
CD40	B-protein
-induced	O
monocyte	O
activation	O
in	O
patients	O
with	O
CD40	B-protein
ligand+	O
hyper	O
IgM	B-protein
syndrome	O
in	O
whom	O
a	O
defect	O
in	O
CD40	B-protein
-induced	O
B	O
cell	O
activation	O
has	O
been	O
reported	O
.	O

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
.	NULL

:	NULL
CURIOX	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Ta	NULL
meJournal	NULL
o	NULL
Activation	NULL
of	NULL
the	NULL
Janus	NULL
Kinase	NULL
3-STAT	NULL
Sa	NULL
*	NULL
Immunol	NULL
Pathway	NULL
After	NULL
CD40	NULL
Triggering	NULL
of	NULL
Human	NULL
unoiogy	NULL
Monocytes	NULL
But	NULL
Not	NULL
of	NULL
Resting	NULL
B	NULL
Cells	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Patrick	NULL
Revy	NULL
,	NULL
Claire	NULL
Hivroz	NULL
,	NULL
Georges	NULL
Andreu	NULL
,	NULL
Pierre	NULL
Graber	NULL
,	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
(	NULL
Elana	NULL
;	NULL
i	NULL
)	NULL
;	NULL
Is	NULL
current	NULL
as	NULL
Chantal	NULL
Martinache	NULL
,	NULL
Alain	NULL
Fischer	NULL
and	NULL
Anne	NULL
Durandy	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:787-793	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/2/787	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
62	NULL
articles	NULL
,	NULL
33	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/2/787.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Activation	NULL
of	NULL
the	NULL
Janus	NULL
Kinase	NULL
3-STAT5a	NULL
Pathway	NULL
After	NULL
CD40	NULL
Triggering	NULL
of	NULL
Human	NULL
Monocytes	NULL
But	NULL
Not	NULL
of	NULL
Resting	NULL
B	NULL
Cells	NULL
Patrick	NULL
Revy	NULL
,	NULL
*	NULL
Claire	NULL
Hivroz	NULL
,	NULL
'	NULL
Georges	NULL
Andreu	NULL
,	NULL
*	NULL
Pierre	NULL
Graber	NULL
,	NULL
``	NULL
Chantal	NULL
Martinache	NULL
,	NULL
*	NULL
Alain	NULL
Fischer	NULL
,	NULL
*	NULL
and	NULL
Anne	NULL
Durandy	NULL
``	NULL
*	NULL
CD40/CD40	NULL
ligand	NULL
interactions	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
immune	NULL
responses	NULL
of	NULL
B	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
dendritic	NULL
cells	NULL
.	NULL

The	NULL
signal	NULL
transduction	NULL
events	NULL
triggered	NULL
by	NULL
cross-linking	NULL
of	NULL
the	NULL
CD40	NULL
receptor	NULL
have	NULL
been	NULL
widely	NULL
studied	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
little	NULL
is	NULL
known	NULL
about	NULL
signaling	NULL
following	NULL
CD40	NULL
stimulation	NULL
of	NULL
monocytes	NULL
and	NULL
resting	NULL
tonsillar	NULL
B	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
CD40	NULL
pathway	NULL
in	NULL
highly	NULL
purified	NULL
human	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

After	NULL
CD40	NULL
triggering	NULL
,	NULL
a	NULL
similar	NULL
activation	NULL
of	NULL
the	NULL
NF-B	NULL
(	NULL
but	NULL
not	NULL
of	NULL
the	NULL
AP-1	NULL
)	NULL
transcription	NULL
factor	NULL
complex	NULL
occurred	NULL
in	NULL
both	NULL
cell	NULL
preparations	NULL
.	NULL

However	NULL
,	NULL
the	NULL
components	NULL
of	NULL
the	NULL
NF-sB	NULL
complexes	NULL
were	NULL
different	NULL
in	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
because	NULL
p50	NULL
is	NULL
part	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
induced	NULL
by	NULL
CD40	NULL
triggering	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
p65	NULL
was	NULL
only	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
although	NULL
the	NULL
Janus	NULL
kinase	NULL
3	NULL
tyrosine	NULL
kinase	NULL
was	NULL
associated	NULL
with	NULL
CD40	NULL
molecules	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
,	NULL
Janus	NULL
kinase	NULL
3	NULL
phosphorylation	NULL
induction	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
CD4O-activated	NULL
monocytes	NULL
,	NULL
with	NULL
subsequent	NULL
induction	NULL
of	NULL
STAT5a	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
activation	NULL
signals	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
differ	NULL
following	NULL
CD40	NULL
stimulation	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
detection	NULL
of	NULL
normal	NULL
CD40-induced	NULL
monocyte	NULL
activation	NULL
in	NULL
patients	NULL
with	NULL
CD40	NULL
ligand	NULL
*	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
in	NULL
whom	NULL
a	NULL
defect	NULL
in	NULL
CD4O0-induced	NULL
B	NULL
cell	NULL
activation	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
:	NULL
787-793	NULL
.	NULL

D40	NULL
is	NULL
a	NULL
50-kDa	NULL
molecule	NULL
that	NULL
is	NULL
present	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
monocytic/dendritic	NULL
cells	NULL
,	NULL
some	NULL
carcinoma	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
human	NULL
thymus	NULL
epithelium	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

The	NULL
CD40-CD40	NULL
ligand	NULL
(	NULL
CD4OL	NULL
)	NULL
®	NULL
interactions	NULL
between	NULL
B	NULL
cells	NULL
and	NULL
activated	NULL
Th	NULL
cells	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
immune	NULL
responses	NULL
and	NULL
have	NULL
therefore	NULL
been	NULL
widely	NULL
studied	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD40	NULL
molecules	NULL
on	NULL
B	NULL
cells	NULL
by	NULL
their	NULL
ligand	NULL
(	NULL
CD4OL/CD154	NULL
)	NULL
causes	NULL
Ig	NULL
class	NULL
switching	NULL
(	NULL
5-10	NULL
)	NULL
,	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
rescue	NULL
from	NULL
apoptosis	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
monocytes	NULL
by	NULL
CD40	NULL
molecules	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNF-a	NULL
)	NULL
,	NULL
up-regulation	NULL
of	NULL
surface	NULL
molecules	NULL
(	NULL
CD54	NULL
,	NULL
CD80	NULL
,	NULL
CD86	NULL
,	NULL
and	NULL
HLA	NULL
class	NULL
II	NULL
)	NULL
,	NULL
tumoricidal	NULL
activity	NULL
(	NULL
15-17	NULL
)	NULL
,	NULL
and	NULL
rescue	NULL
from	NULL
apoptosis	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
CD40	NULL
stimulation	NULL
of	NULL
dendritic	NULL
cells	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
defense	NULL
against	NULL
pathogens	NULL
,	NULL
because	NULL
large	NULL
amounts	NULL
of	NULL
IL-12	NULL
are	NULL
produced	NULL
(	NULL
19	NULL
)	NULL
and	NULL
specific	NULL
T	NULL
cell	NULL
cytotoxicity	NULL
is	NULL
induced	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
CD4O-	NULL
and	NULL
CD4OL-deficient	NULL
mice	NULL
(	NULL
23-27	NULL
)	NULL
and	NULL
human	NULL
patients	NULL
with	NULL
CD4OL	NULL
mutations	NULL
(	NULL
X-linked	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
)	NULL
(	NULL
28-32	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
CD40-CD40L	NULL
in	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
Unité	NULL
429	NULL
,	NULL
Hopital	NULL
Necker-Enfants	NULL
Malades	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
Unité	NULL
520	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
*Etablissement	NULL
de	NULL
Transfusion	NULL
Sanguine	NULL
de	NULL
l'Assistance	NULL
Publique-Hopitaux	NULL
de	NULL
Paris	NULL
,	NULL
Site	NULL
Saint-Antoine	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
and	NULL
©Serono	NULL
Pharmaceuticals	NULL
Research	NULL
Institute	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
14	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
28	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
Assistance	NULL
Publique/Hopitaux	NULL
de	NULL
Paris	NULL
,	NULL
and	NULL
Association	NULL
Fran-gaise	NULL
Contre	NULL
les	NULL
Myopathies	NULL
(	NULL
AFM	NULL
)	NULL
.	NULL

P.R	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
doctoral	NULL
fellowship	NULL
from	NULL
Ministre	NULL
de	NULL
1'Education	NULL
Nationale	NULL
,	NULL
de	NULL
la	NULL
Recherche	NULL
,	NULL
et	NULL
de	NULL
la	NULL
Technologic	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Anne	NULL
Durandy	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
Unité	NULL
429	NULL
,	NULL
Hopital	NULL
Necker-Enfants	NULL
Malades	NULL
,	NULL
149	NULL
rue	NULL
de	NULL
S	NULL
&	NULL
vres	NULL
,	NULL
75015	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
Durandy	NULL
@	NULL
necker.fr	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CD4O0L	NULL
,	NULL
CD40	NULL
ligand	NULL
;	NULL
sCD4O0L	NULL
,	NULL
soluble	NULL
CDA4OL	NULL
;	NULL
Jak	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
TRAF	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
GRR	NULL
,	NULL
y	NULL
response	NULL
region	NULL
;	NULL
B-CAS	NULL
,	NULL
B-casein	NULL
;	NULL
IRF	NULL
,	NULL
IFN	NULL
regulatory	NULL
factor	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
teractions	NULL
are	NULL
essential	NULL
for	NULL
cellular	NULL
immune	NULL
responses	NULL
against	NULL
intracellular	NULL
pathogens	NULL
.	NULL

Another	NULL
form	NULL
of	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
secondary	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
CD40	NULL
activation	NULL
pathway	NULL
in	NULL
B	NULL
cells	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
33-35	NULL
)	NULL
(	NULL
CD4OL	NULL
*	NULL
hyper	NULL
IgM	NULL
)	NULL
.	NULL

Patients	NULL
with	NULL
this	NULL
syndrome	NULL
have	NULL
a	NULL
defect	NULL
in	NULL
Ig	NULL
switching	NULL
but	NULL
are	NULL
not	NULL
susceptible	NULL
to	NULL
infection	NULL
by	NULL
intracellular	NULL
pathogens	NULL
;	NULL
these	NULL
patients	NULL
exhibit	NULL
normal	NULL
in	NULL
vitro	NULL
CD4O-stimulated	NULL
monocyte	NULL
and	NULL
dendritic	NULL
cell	NULL
activities	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
CD4OL	NULL
or	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
CD40	NULL
activation	NULL
pathways	NULL
of	NULL
B	NULL
lymphocytes	NULL
and	NULL
monocytes/dendritic	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
latter	NULL
hypothesis	NULL
by	NULL
comparing	NULL
the	NULL
biochemical	NULL
events	NULL
induced	NULL
by	NULL
the	NULL
CD40	NULL
stimulation	NULL
of	NULL
highly	NULL
purified	NULL
human	NULL
resting	NULL
B	NULL
cells	NULL
and	NULL
elutriated	NULL
monocytes	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
biochemical	NULL
events	NULL
induced	NULL
by	NULL
the	NULL
CD40	NULL
activation	NULL
of	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
,	NULL
because	NULL
most	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
preactivated	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

Several	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
CD40	NULL
activation	NULL
of	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

They	NULL
include	NULL
protein	NULL
kinases	NULL
such	NULL
as	NULL
phosphatidylinositol-3-kinase	NULL
,	NULL
phospholipase	NULL
C-y2	NULL
,	NULL
and	NULL
lyn	NULL
,	NULL
which	NULL
are	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
complexes	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-AT	NULL
,	NULL
which	NULL
are	NULL
induced	NULL
(	NULL
33	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Proteins	NULL
of	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
(	NULL
TRAF	NULL
)	NULL
family	NULL
(	NULL
TRAF2	NULL
,	NULL
TRAF3	NULL
,	NULL
TRAF5	NULL
,	NULL
and	NULL
TRAF6	NULL
)	NULL
and	NULL
others	NULL
(	NULL
TRAF	NULL
family	NULL
member	NULL
associated	NULL
NF-KB	NULL
activator	NULL
(	NULL
TANK	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
,	NULL
and	NULL
c	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
protein	NULL
(	NULL
clAP	NULL
)	NULL
)	NULL
(	NULL
40-45	NULL
)	NULL
interact	NULL
directly	NULL
or	NULL
indirectly	NULL
with	NULL
the	NULL
intracytoplasmic	NULL
tail	NULL
of	NULL
CD40	NULL
and	NULL
are	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
tyrosine	NULL
kinase	NULL
Janus	NULL
kinase	NULL
3	NULL
(	NULL
Jak3	NULL
)	NULL
has	NULL
been	NULL
found	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
in	NULL
which	NULL
it	NULL
interacts	NULL
with	NULL
CD40	NULL
.	NULL

It	NULL
is	NULL
tyrosine-phosphorylated	NULL
after	NULL
CD40	NULL
triggering	NULL
and	NULL
induces	NULL
STAT3	NULL
translocation	NULL
(	NULL
46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
was	NULL
detected	NULL
in	NULL
CD4O-activated	NULL
murine	NULL
spleen	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
STAT6	NULL
induction	NULL
was	NULL
reported	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
a	NULL
more	NULL
recent	NULL
study	NULL
,	NULL
Jabara	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
that	NULL
CD40	NULL
signaling	NULL
in	NULL
Jak3-deficient	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
including	NULL
up-regulation	NULL
of	NULL
membrane	NULL
marker	NULL
expression	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
Ig	NULL
switching	NULL
,	NULL
is	NULL
functional	NULL
(	NULL
48	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
demonstrates	NULL
that	NULL
Jak3	NULL
is	NULL
not	NULL
required	NULL
for	NULL
CD40	NULL
phs	NULL
cytokine-induced	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
788	NULL
COMPARISON	NULL
OF	NULL
CD40	NULL
PATHWAY	NULL
IN	NULL
HUMAN	NULL
MONOCYTES	NULL
AND	NULL
B	NULL
CELLS	NULL
We	NULL
investigated	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
protein	NULL
Jak3	NULL
to	NULL
better	NULL
delineate	NULL
CD40-mediated	NULL
activation	NULL
pathways	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
obtained	NULL
evidence	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
but	NULL
not	NULL
AP-1	NULL
)	NULL
transcription	NULL
factors	NULL
in	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
after	NULL
CD40	NULL
triggering	NULL
.	NULL

Jak3	NULL
was	NULL
similarly	NULL
associated	NULL
with	NULL
CD40	NULL
molecules	NULL
in	NULL
both	NULL
cell	NULL
populations	NULL
,	NULL
but	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
monocytes	NULL
after	NULL
CD40	NULL
cross-linking	NULL
.	NULL

STAT5a	NULL
was	NULL
induced	NULL
in	NULL
activated	NULL
monocytes	NULL
,	NULL
but	NULL
no	NULL
STAT	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
after	NULL
the	NULL
CD40	NULL
stimulation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
there	NULL
are	NULL
differences	NULL
in	NULL
the	NULL
CD40	NULL
activation	NULL
pathways	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
preparations	NULL
PBMCs	NULL
that	NULL
had	NULL
been	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
by	NULL
leukapheresis	NULL
were	NULL
subjected	NULL
to	NULL
Ficoll-Hypaque	NULL
density	NULL
centrifugation	NULL
.	NULL

The	NULL
mononuclear	NULL
cell	NULL
interface	NULL
was	NULL
further	NULL
separated	NULL
into	NULL
a	NULL
monocyte-enriched	NULL
fraction	NULL
by	NULL
coun-tercurrent	NULL
centrifugal	NULL
elutriation	NULL
using	NULL
a	NULL
Beckman	NULL
J6	NULL
M/E	NULL
centrifuge	NULL
with	NULL
a	NULL
JE-5.0	NULL
elutriator	NULL
rotor	NULL
(	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

We	NULL
used	NULL
the	NULL
technique	NULL
described	NULL
by	NULL
Faradji	NULL
et	NULL
al	NULL
.	NULL

(	NULL
49	NULL
)	NULL
,	NULL
slightly	NULL
modified	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
elutriation	NULL
medium	NULL
,	NULL
with	NULL
Hank	NULL
's	NULL
medium	NULL
replaced	NULL
by	NULL
a	NULL
phosphate	NULL
buffer	NULL
.	NULL

The	NULL
monocyte	NULL
preparation	NULL
was	NULL
>	NULL
90	NULL
%	NULL
pure	NULL
as	NULL
assessed	NULL
by	NULL
CD14	NULL
staining	NULL
,	NULL
with	NULL
<	NULL
2	NULL
%	NULL
B	NULL
lymphocytes	NULL
.	NULL

Tonsillar	NULL
B	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
passing	NULL
tonsil	NULL
specimens	NULL
through	NULL
mesh	NULL
and	NULL
rosetting	NULL
with	NULL
2-aminoethyl-isothiouronium	NULL
bromide-treated	NULL
SR-BCs	NULL
to	NULL
remove	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
subjected	NULL
to	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
and	NULL
subsequently	NULL
centrifuged	NULL
through	NULL
a	NULL
discontinuous	NULL
Percoll	NULL
gradient	NULL
to	NULL
isolate	NULL
small	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
cell	NULL
population	NULL
(	NULL
recovered	NULL
from	NULL
the	NULL
50-55	NULL
%	NULL
interface	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
immunofluorescence	NULL
.	NULL

More	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
CD19*	NULL
,	NULL
p*	NULL
,	NULL
8*	NULL
.	NULL

Contaminating	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
accounted	NULL
for	NULL
<	NULL
5	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Abs	NULL
and	NULL
reagents	NULL
For	NULL
immunofluorescence	NULL
studies	NULL
,	NULL
FITC-labeled	NULL
anti-CD40	NULL
mAb	NULL
was	NULL
purchased	NULL
from	NULL
Diaclone	NULL
(	NULL
Besangon	NULL
,	NULL
France	NULL
)	NULL
,	NULL
PE-labeled	NULL
anti-CD14	NULL
Ab	NULL
and	NULL
PE-labeled	NULL
anti-CD19	NULL
Ab	NULL
were	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Moun-tain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
FITC-labeled	NULL
polyclonal	NULL
Abs	NULL
directed	NULL
against	NULL
IgM	NULL
and	NULL
IgD	NULL
were	NULL
purchased	NULL
from	NULL
Caltag	NULL
(	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
activation	NULL
studies	NULL
,	NULL
the	NULL
anti-CD40	NULL
mAb	NULL
BB20	NULL
and	NULL
an	NULL
irrelevant	NULL
mouse	NULL
IgG1	NULL
control	NULL
were	NULL
obtained	NULL
from	NULL
Diaclone	NULL
and	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
.	NULL

The	NULL
soluble	NULL
CD4O0L	NULL
(	NULL
sCD4O0L	NULL
)	NULL
,	NULL
which	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
50	NULL
)	NULL
,	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
.	NULL

Tonomycin	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
PMA	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

IL-4	NULL
was	NULL
obtained	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
Abs	NULL
against	NULL
Jak3	NULL
,	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
STAT1	NULL
(	NULL
p84/	NULL
p91	NULL
)	NULL
,	NULL
STAT2	NULL
,	NULL
STAT4	NULL
,	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
STAT5a	NULL
(	NULL
sc-1081	NULL
X	NULL
)	NULL
,	NULL
and	NULL
STAT6	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
as	NULL
was	NULL
the	NULL
anti-CD40	NULL
Ab	NULL
(	NULL
sc-974	NULL
)	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

The	NULL
Ab	NULL
directed	NULL
to	NULL
the	NULL
p50	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
kindly	NULL
donated	NULL
by	NULL
R.	NULL
Weil	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
antiphosphotyrosine	NULL
Ab	NULL
4G10	NULL
and	NULL
the	NULL
anti-STAT3	NULL
Ab	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
N-terminal	NULL
part	NULL
of	NULL
STATS5a	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
B.	NULL
Groner	NULL
(	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Tumor	NULL
Biology	NULL
Center	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Monocytes	NULL
or	NULL
resting	NULL
B	NULL
cells	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
activated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
RPMI	NULL
1640	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
anti-CD40	NULL
mAb	NULL
BB20	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
sCD40L	NULL
(	NULL
10	NULL
g/tol	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
107°	NULL
M	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
in	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
52	NULL
)	NULL
,	NULL
with	NULL
minor	NULL
changes	NULL
in	NULL
procedure	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
swell	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
PMSF	NULL
)	NULL
containing	NULL
the	NULL
following	NULL
protease	NULL
inhibitors	NULL
:	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
antipain	NULL
,	NULL
each	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
4	NULL
pg/ml	NULL
for	NULL
monocytes	NULL
and	NULL
2	NULL
ug/ml	NULL
for	NULL
B	NULL
cells	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
25	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
PMSF	NULL
)	NULL
containing	NULL
the	NULL
protease	NULL
inhibitors	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
left	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cell	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
nuclear	NULL
extracts	NULL
were	NULL
stored	NULL
at	NULL
Monocytes	NULL
a.	NULL
a	NULL
3	NULL
E	NULL
o	NULL
o	NULL
$	NULL
§8	NULL
o	NULL
o	NULL
$	NULL
§	NULL
&	NULL
&	NULL
&	NULL
&	NULL
£	NULL
a	NULL
2	NULL
°8	NULL
g	NULL
a	NULL
°	NULL
Sg	NULL
3	NULL
43	NULL
t	NULL
+s	NULL
3	NULL
§	NULL
t	NULL
+s	NULL
$	NULL
$	NULL
pgs	NULL
Seine	NULL
A	NULL
-	NULL
s	NULL
%	NULL
&	NULL
&	NULL
+	NULL
B	NULL
S	NULL
$	NULL
%	NULL
&	NULL
E	NULL
?	NULL

‘	NULL
\	NULL
AP-1	NULL
»	NULL
bo	NULL
4	NULL
wee	NULL
z	NULL
)	NULL
fb	NULL
``	NULL
O	NULL
He	NULL
°	NULL
_	NULL
-	NULL
re	NULL
Resting	NULL
B	NULL
cells	NULL
a.	NULL
a	NULL
.	NULL

§	NULL
5	NULL
0	NULL
s	NULL
g8	NULL
g	NULL
go	NULL
g	NULL
a	NULL
3	NULL
$	NULL
$	NULL
go	NULL
a	NULL
2	NULL
8§	NULL
3	NULL
g	NULL
i	NULL
:	NULL
s	NULL
3	NULL
g	NULL
<	NULL
<	NULL
8	NULL
©	NULL
o	NULL
0	NULL
G	NULL
o	NULL
®	NULL
$	NULL
o	NULL
=	NULL
0	NULL
C	NULL
a	NULL
3	NULL
E	NULL
Es	NULL
.	NULL
)	NULL

D	NULL
=	NULL
o	NULL
o	NULL
o	NULL
+	NULL
>	NULL
AP-1	NULL
»	NULL
vee	NULL
z	NULL
sl	NULL
f	NULL
nsp	NULL
»	NULL
FIGURE	NULL
1	NULL
.	NULL

Induction	NULL
of	NULL
NF-KB	NULL
but	NULL
not	NULL
of	NULL
AP-1	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
stimulated	NULL
via	NULL
the	NULL
CD40	NULL
receptor	NULL
.	NULL

Monocytes	NULL
(	NULL
20	NULL
%	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
by	NULL
incubation	NULL
with	NULL
sCD4O0L	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
107°	NULL
M	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
tested	NULL
in	NULL
EMSAs	NULL
using	NULL
a	NULL
labeled	NULL
probe	NULL
specific	NULL
for	NULL
NF-xB	NULL
(	NULL
4	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
human	NULL
resting	NULL
B	NULL
cells	NULL
and	NULL
NF-KB	NULL
(	NULL
C	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
free-labeled	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
nonspecific	NULL
signal	NULL
(	NULL
nsp	NULL
)	NULL
is	NULL
also	NULL
indicated	NULL
.	NULL

Binding	NULL
specificity	NULL
was	NULL
assessed	NULL
using	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
anti-CD40	NULL
mAb	NULL
B220	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Five	NULL
independent	NULL
experiments	NULL
were	NULL
conducted	NULL
,	NULL
and	NULL
the	NULL
results	NULL
shown	NULL
are	NULL
typical	NULL
.	NULL

-70°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5-10	NULL
pug	NULL
protein	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
DNA-binding	NULL
activity	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
gl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Monocytes	NULL
Resting	NULL
B	NULL
cells	NULL
Activation	NULL
with	NULL
sCD40L	NULL
Activation	NULL
with	NULL
sCD40L	NULL
and	NULL
supershift	NULL
with	NULL
and	NULL
supershift	NULL
with	NULL
--	NULL
--	NULL
--	NULL
_-	NULL
--	NULL
-a	NULL
$	NULL
0	NULL
&	NULL
f	NULL
ip	NULL
oe	NULL
£0	NULL
5	NULL
%	NULL
ff	NULL
aA	NULL
~	NULL
``	NULL
real	NULL
»	NULL
#	NULL
A	NULL
#	NULL
®	NULL
#	NULL
*	NULL
%	NULL
#	NULL
ags	NULL
31°	NULL
|	NULL
HHW	NULL
FIGURE	NULL
2	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
by	NULL
CD40	NULL
activation	NULL
are	NULL
different	NULL
in	NULL
nuclei	NULL
from	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Supershift	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
specific	NULL
Abs	NULL
directed	NULL
against	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
components	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
subsequently	NULL
adding	NULL
labeled	NULL
NF-KB	NULL
probe	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
monocytes	NULL
(	NULL
A	NULL
)	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

60	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.3	NULL
mM	NULL
DTT	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
3	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
separately	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
each	NULL
of	NULL
the	NULL
double-stranded	NULL
labeled	NULL
probes	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5-GATCCCAA	NULL
GAGGGATTTCACCTAAATCC-3	NULL
'	NULL
)	NULL
,	NULL
for	NULL
AP-1	NULL
(	NULL
5-GATCCGCTTGAT	NULL
GACTCAGCCGGAA-3	NULL
``	NULL
)	NULL
,	NULL
and	NULL
for	NULL
STAT	NULL
factors	NULL
with	NULL
the	NULL
y	NULL
response	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
probe	NULL
from	NULL
the	NULL
FeyRI	NULL
gene	NULL
(	NULL
5-ATTTCCCAGAAAAGAC	NULL
CCTTTAT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
nondenaturing	NULL
5	NULL
%	NULL
poly	NULL
acrylamide	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
at	NULL
14	NULL
V/cm	NULL
in	NULL
a	NULL
low-ionic-strength	NULL
buffer	NULL
(	NULL
0.5	NULL
%	NULL
Tris	NULL
boric	NULL
acid	NULL
EDTA	NULL
buffer	NULL
(	NULL
TBE	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
examined	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunny-vale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
conducted	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
added	NULL
to	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
for	NULL
STAT	NULL
competition	NULL
assays	NULL
were	NULL
the	NULL
y-activated	NULL
site	NULL
of	NULL
the	NULL
IFN	NULL
regulator	NULL
factor-1	NULL
(	NULL
IRF-1	NULL
)	NULL
gene	NULL
promoter	NULL
(	NULL
5'-GATCCATTTCCCCGAAA	NULL
TGA-3	NULL
'	NULL
)	NULL
(	NULL
53	NULL
)	NULL
and	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
bovine	NULL
B-casein	NULL
(	NULL
B-CAS	NULL
)	NULL
gene	NULL
promoter	NULL
(	NULL
5-AGATTTCTAGGAATTCAAATC-3	NULL
'	NULL
)	NULL
(	NULL
54	NULL
)	NULL
.	NULL

IRF-1	NULL
and	NULL
B-CAS	NULL
probes	NULL
are	NULL
both	NULL
STAT	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

For	NULL
supershift	NULL
assay	NULL
,	NULL
specific	NULL
Abs	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
components	NULL
(	NULL
p50	NULL
,	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
)	NULL
were	NULL
added	NULL
;	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
before	NULL
adding	NULL
labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

Anti-STAT	NULL
Abs	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
were	NULL
added	NULL
during	NULL
incubation	NULL
with	NULL
the	NULL
STAT-labeled	NULL
probe	NULL
.	NULL

Immunoprecipitation	NULL
Monocytes	NULL
or	NULL
small	NULL
resting	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
anti-CD40	NULL
mAb	NULL
BB20	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

or	NULL
the	NULL
irrelevant	NULL
IgG1	NULL
control	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
various	NULL
times	NULL
(	NULL
from	NULL
1	NULL
to	NULL
30	NULL
min	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
or	NULL
0.5	NULL
%	NULL
for	NULL
coimmunoprecipitation	NULL
)	NULL
,	NULL
0.14	NULL
M	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
or-thovanadate	NULL
,	NULL
2	NULL
mM	NULL
PMSF	NULL
,	NULL
2	NULL
%	NULL
aprotinin	NULL
,	NULL
and	NULL
2-4	NULL
pg/ml	NULL
pepstatin	NULL
,	NULL
antipain	NULL
,	NULL
and	NULL
leupeptin	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
centrifuged	NULL
for	NULL
20	NULL
min	NULL
;	NULL
the	NULL
postnuclear	NULL
extract	NULL
was	NULL
cleared	NULL
by	NULL
incubation	NULL
with	NULL
rabbit	NULL
IgG	NULL
(	NULL
2	NULL
ug	NULL
,	NULL
Sigma	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
was	NULL
added	NULL
to	NULL
precipitate	NULL
nonspecific	NULL
immune	NULL
complexes	NULL
.	NULL

The	NULL
cleared	NULL
postnuclear	NULL
extract	NULL
was	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
specific	NULL
Ab	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
was	NULL
added	NULL
to	NULL
pre-	NULL
789	NULL
Monocytes	NULL
Resting	NULL
B	NULL
cells	NULL
o	NULL
co	NULL
o	NULL
&	NULL
IP	NULL
:	NULL
B0	NULL
§	NULL
0	NULL
$	NULL
a	NULL
$	NULL
0	NULL
f	NULL
.	NULL

o	NULL
3	NULL
ins	NULL
0	NULL
Z	NULL
~	NULL
>	NULL
IB	NULL
Anti-Jak3	NULL
3	NULL
Jag	NULL
>	NULL
.	NULL

Jak3	NULL
-	NULL
»	NULL
es	NULL
»	NULL
FIGURE	NULL
3	NULL
.	NULL

Jak3	NULL
is	NULL
associated	NULL
with	NULL
CD40	NULL
in	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Lysates	NULL
from	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
anti-Jak3	NULL
Ab	NULL
,	NULL
anti-CD40	NULL
mAb	NULL
,	NULL
or	NULL
rabbit	NULL
IgG	NULL
control	NULL
(	NULL
nonspecific	NULL
signal	NULL
(	NULL
NSP	NULL
)	NULL
)	NULL
and	NULL
were	NULL
Western-blotted	NULL
using	NULL
the	NULL
anti-Jak3	NULL
Ab	NULL
.	NULL

**	NULL
,	NULL
110-kDa	NULL
Jak3	NULL
form	NULL
cipitate	NULL
the	NULL
immune	NULL
complexes	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
washed	NULL
several	NULL
times	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
suspended	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
electrophoretic	NULL
transfer	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Immobilon-P	NULL
,	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
Ab	NULL
or	NULL
with	NULL
the	NULL
Ab	NULL
of	NULL
interest	NULL
,	NULL
with	NULL
detection	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
stripped	NULL
from	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
by	NULL
incubating	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50°C	NULL
in	NULL
62.5	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
2-ME	NULL
,	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
several	NULL
times	NULL
in	NULL
PBS	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
subsequently	NULL
reprobed	NULL
.	NULL

Results	NULL
CD40-mediated	NULL
stimulation	NULL
of	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
activated	NULL
NF-xB	NULL
but	NULL
not	NULL
AP-1	NULL
CD40	NULL
triggering	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
complexes	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
33	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
CD4O0-stimulated	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cell	NULL
preparations	NULL
by	NULL
EMSAs	NULL
with	NULL
specific	NULL
labeled	NULL
oligonucleotides	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
monocyte	NULL
nuclei	NULL
after	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
sCD4O0L	NULL
or	NULL
the	NULL
anti-CD40	NULL
BB20	NULL
mAb	NULL
(	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
IgG1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
AP-1	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
was	NULL
obtained	NULL
for	NULL
the	NULL
nuclei	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
sCD40L	NULL
or	NULL
anti-€CD40	NULL
mAb	NULL
,	NULL
with	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
not	NULL
AP-1	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
if	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
=3	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
the	NULL
positive	NULL
control	NULL
,	NULL
activated	NULL
both	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
the	NULL
same	NULL
components	NULL
were	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
by	NULL
CD40	NULL
stimulation	NULL
in	NULL
nuclei	NULL
from	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
by	NULL
performing	NULL
supershift	NULL
assays	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
populations	NULL
,	NULL
anti-p50	NULL
Abs	NULL
caused	NULL
a	NULL
complete	NULL
supershift	NULL
,	NULL
whereas	NULL
anti-c-Rel	NULL
Abs	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Anti-p65	NULL
Abs	NULL
caused	NULL
only	NULL
a	NULL
partial	NULL
supershift	NULL
in	NULL
nuclei	NULL
from	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
no	NULL
supershift	NULL
in	NULL
nuclei	NULL
from	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
indicates	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
resulting	NULL
from	NULL
CD40	NULL
activation	NULL
in	NULL
nuclei	NULL
from	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
contain	NULL
p50	NULL
;	NULL
however	NULL
,	NULL
p65	NULL
is	NULL
present	NULL
only	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Jak3	NULL
is	NULL
associated	NULL
with	NULL
CD40	NULL
in	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
Hanissian	NULL
and	NULL
Geha	NULL
showed	NULL
that	NULL
CD40	NULL
interacts	NULL
with	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Jak3	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
it	NULL
could	NULL
be	NULL
also	NULL
detected	NULL
in	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
by	NULL
coim-munoprecipitation	NULL
with	NULL
an	NULL
anti-CD40	NULL
Ab	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-Jak3	NULL
Ab	NULL
.	NULL

A	NULL
band	NULL
was	NULL
detected	NULL
on	NULL
the	NULL
Western	NULL
blot	NULL
at	NULL
~115	NULL
kDa	NULL
;	NULL
this	NULL
size	NULL
corresponds	NULL
to	NULL
that	NULL
of	NULL
the	NULL
Jak3	NULL
protein	NULL
in	NULL
lysates	NULL
from	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
,	NULL
indicating	NULL
a	NULL
Jak3	NULL
interaction	NULL
with	NULL
CD40	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
monocyte	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
790	NULL
Monocytes	NULL
A	NULL
Anti-Jak3	NULL
|	NULL
time	NULL
of	NULL
CD40	NULL
I	NULL
stimulation	NULL
(	NULL
min	NULL
)	NULL
0	NULL
-	NULL
Blot	NULL
:	NULL
®	NULL
J	NULL
Z	NULL
-	NULL
Anti-phosphotyrosine	NULL
Y	NULL
0	NULL
1	NULL
5	NULL
15	NULL
30	NULL
zl	NULL
``	NULL
T	NULL
T	NULL
T	NULL
T	NULL
--	NULL
*	NULL
<	NULL
Jak3	NULL
Blot	NULL
:	NULL
Anti-Jak3	NULL
-	NULL
<	NULL
Jak3	NULL
~*~	NULL
*	NULL
*	NULL
COMPARISON	NULL
OF	NULL
CD40	NULL
PATHWAY	NULL
IN	NULL
HUMAN	NULL
MONOCYTES	NULL
AND	NULL
B	NULL
CELLS	NULL
Resting	NULL
B	NULL
cells	NULL
Anti-Jak3	NULL
|	NULL
time	NULL
of	NULL
CD40	NULL
I	NULL
stimulation	NULL
(	NULL
min	NULL
)	NULL
%	NULL
0	NULL
_	NULL
Blot	NULL
:	NULL
L4	NULL
&	NULL
«	NULL
=	NULL
Z	NULL
Anti-phosphotyrosine	NULL
IgG1	NULL
0	NULL
5	NULL
15	NULL
30	NULL
Blot	NULL
:	NULL
Anti-Jak3	NULL
«	NULL
t	NULL
--	NULL
»	NULL
a-	NULL
»	NULL
ue	NULL
c-	NULL
»	NULL
ane	NULL
--	NULL
Jak3	NULL
Ins	NULL
FIGURE	NULL
4	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
ligation	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Monocytes	NULL
(	NULL
A	NULL
)	NULL
or	NULL
resting	NULL
B	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
(	NULL
20	NULL
%	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
with	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
control	NULL
IgG1	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Jak3	NULL
Ab	NULL
or	NULL
purified	NULL
rabbit	NULL
IgG	NULL
(	NULL
nonspecific	NULL
signal	NULL
(	NULL
NSP	NULL
)	NULL
)	NULL
and	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
Ab	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Jak3	NULL
Ab	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

*	NULL
,	NULL
Jak3-associated	NULL
phosphorylated	NULL
protein	NULL
.	NULL

**	NULL
,	NULL
110-kDa	NULL
Jak3	NULL
form	NULL
.	NULL

sCD4O0L	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

activation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
were	NULL
conducted	NULL
,	NULL
and	NULL
the	NULL
results	NULL
shown	NULL
are	NULL
typical	NULL
.	NULL

preparations	NULL
,	NULL
a	NULL
slightly	NULL
smaller	NULL
(	NULL
~110-kDa	NULL
)	NULL
protein	NULL
was	NULL
also	NULL
detected	NULL
with	NULL
the	NULL
anti-Jak3	NULL
Ab	NULL
.	NULL

This	NULL
band	NULL
may	NULL
correspond	NULL
to	NULL
a	NULL
degraded	NULL
form	NULL
of	NULL
Jak3	NULL
because	NULL
monocyte	NULL
protein	NULL
extracts	NULL
are	NULL
rich	NULL
in	NULL
proteases	NULL
.	NULL

It	NULL
may	NULL
also	NULL
correspond	NULL
to	NULL
a	NULL
shorter	NULL
isoform	NULL
of	NULL
Jak3	NULL
that	NULL
is	NULL
present	NULL
only	NULL
in	NULL
monocytes	NULL
.	NULL

CD40-mediated	NULL
stimulation	NULL
of	NULL
monocytes	NULL
but	NULL
not	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
As	NULL
Jak3	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
CD40	NULL
molecules	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
in	NULL
CD4O0-stimulated	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
preparations	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
or	NULL
a	NULL
control	NULL
IgG1	NULL
)	NULL
or	NULL
IL-4	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
;	NULL
next	NULL
,	NULL
the	NULL
Jak3	NULL
protein	NULL
was	NULL
immunopre-cipitated	NULL
,	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
its	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
as-sessed	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
anti-CD40	NULL
mAb	NULL
activation	NULL
(	NULL
but	NULL
not	NULL
activation	NULL
by	NULL
the	NULL
IgG1	NULL
control	NULL
)	NULL
induced	NULL
Jak3	NULL
phosphorylation	NULL
after	NULL
1-30	NULL
min	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
115-kDa	NULL
band	NULL
was	NULL
phos-phorylated	NULL
;	NULL
the	NULL
second	NULL
band	NULL
(	NULL
110	NULL
kDa	NULL
)	NULL
was	NULL
not	NULL
.	NULL

A	NULL
higher	NULL
molecular	NULL
mass	NULL
phosphorylated	NULL
band	NULL
(	NULL
120	NULL
kDa	NULL
,	NULL
not	NULL
found	NULL
in	NULL
IL-4-stim-ulated	NULL
monocytes	NULL
)	NULL
,	NULL
precipitated	NULL
with	NULL
Jak3	NULL
,	NULL
was	NULL
also	NULL
detected	NULL
.	NULL

This	NULL
band	NULL
was	NULL
not	NULL
detected	NULL
on	NULL
the	NULL
anti-Jak3	NULL
Ab	NULL
immunoblot	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
;	NULL
therefore	NULL
,	NULL
it	NULL
may	NULL
correspond	NULL
to	NULL
a	NULL
Jak3-associated	NULL
,	NULL
tyrosine-phosphorylated	NULL
protein	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
by	NULL
either	NULL
the	NULL
s€CD40L	NULL
or	NULL
anti-CD40	NULL
mAb	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
although	NULL
significant	NULL
amounts	NULL
of	NULL
Jak3	NULL
were	NULL
precipitated	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
and	NULL
coprecipitated	NULL
with	NULL
CD40	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
incubation	NULL
with	NULL
IL-4	NULL
,	NULL
the	NULL
positive	NULL
control	NULL
,	NULL
consistently	NULL
induced	NULL
Jak3	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
CD4O0-mediated	NULL
Jak3	NULL
activation	NULL
did	NULL
not	NULL
result	NULL
from	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
CD40	NULL
molecules	NULL
,	NULL
because	NULL
a	NULL
similar	NULL
level	NULL
of	NULL
CD40	NULL
receptors	NULL
was	NULL
present	NULL
on	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

CD40-mediated	NULL
stimulation	NULL
of	NULL
monocytes	NULL
but	NULL
not	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
induced	NULL
STAT35a	NULL
activation	NULL
Jak	NULL
tyrosine	NULL
kinases	NULL
transduce	NULL
signals	NULL
via	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
transcription	NULL
factors	NULL
,	NULL
leading	NULL
to	NULL
STAT	NULL
dimerization	NULL
,	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
binding	NULL
to	NULL
DNA	NULL
sequences	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
induction	NULL
of	NULL
STAT	NULL
molecules	NULL
following	NULL
the	NULL
CD40	NULL
stimulation	NULL
of	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
30-min	NULL
incubation	NULL
of	NULL
monocytes	NULL
with	NULL
the	NULL
anti-€CD40	NULL
mAb	NULL
BB20	NULL
(	NULL
but	NULL
not	NULL
with	NULL
the	NULL
control	NULL
IgG1	NULL
)	NULL
activated	NULL
STAT	NULL
proteins	NULL
because	NULL
the	NULL
labeled	NULL
GRR	NULL
probe	NULL
was	NULL
retained	NULL
on	NULL
the	NULL
gel	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
competitive	NULL
assays	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
IRF-1	NULL
or	NULL
B-CAS	NULL
probes	NULL
(	NULL
both	NULL
containing	NULL
STAT	NULL
consensus	NULL
binding	NULL
sites	NULL
)	NULL
led	NULL
to	NULL
the	NULL
complete	NULL
disappearance	NULL
of	NULL
the	NULL
sig-nal	NULL
,	NULL
confirming	NULL
induction	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
STAT	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
STAT3	NULL
,	NULL
STATA	NULL
,	NULL
and	NULL
STAT6	NULL
Monocytes	NULL
Resting	NULL
B	NULL
cells	NULL
FIGURE	NULL
5	NULL
.	NULL

Expression	NULL
of	NULL
CD40	NULL
molecules	NULL
on	NULL
elu-	NULL
I	NULL
triated	NULL
monocytes	NULL
and	NULL
tonsillar	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Double	NULL
i	NULL
¢	NULL
immunofluorescence	NULL
staining	NULL
was	NULL
performed	NULL
with	NULL
FITC	NULL
-	NULL
/	NULL
anti-CD40	NULL
mAb	NULL
and	NULL
PE-Jabeled	NULL
anti-CD14	NULL
or	NULL
anti-	NULL
-	NULL
@	NULL
10°	NULL
4s	NULL
1	NULL
10°	NULL
M	NULL
CD13-PE	NULL
--	NULL
-	NULL
CD19	NULL
mAb	NULL
.	NULL

1D1	NULL
(	NULL
a	NULL
'	NULL
as	NULL
as	NULL
ad	NULL
--	NULL
-	NULL
CAOATC	NULL
--	NULL
-	NULL
rrr	NULL
.	NULL

(	NULL
rrr	NULL
ror	NULL
rim	NULL
10°	NULL
10°	NULL
10	NULL
CAOATC	NULL
--	NULL
-	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Monocytes	NULL
FIGURE	NULL
6	NULL
.	NULL

Activation	NULL
of	NULL
STAT	NULL
molecules	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
ligation	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Monocytes	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
with	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
10	NULL
ug/	NULL
ml	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
EMSAs	NULL
with	NULL
labeled	NULL
GRR	NULL
probes	NULL
.	NULL

A	NULL
,	NULL
Competitive	NULL
assays	NULL
of	NULL
STAT	NULL
binding	NULL
activity	NULL
were	NULL
done	NULL
using	NULL
a	NULL
50-fold	NULL
A	NULL
excess	NULL
of	NULL
unlabeled	NULL
STAT	NULL
consensus	NULL
binding	NULL
probe	NULL
,	NULL
either	NULL
IRF-1	NULL
or	NULL
B-CAS	NULL
.	NULL

B	NULL
,	NULL
B	NULL
cells	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
10	NULL
pg/	NULL
ml	NULL
)	NULL
,	NULL
IgG1	NULL
(	NULL
10	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
or	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
EMSAs	NULL
with	NULL
labeled	NULL
GRR	NULL
probes	NULL
.	NULL

C	NULL
,	NULL
Band	NULL
shift	NULL
analysis	NULL
of	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
as	NULL
for	NULL
B	NULL
,	NULL
with	NULL
labeled	NULL
probe	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Two	NULL
independent	NULL
experiments	NULL
were	NULL
conducted	NULL
,	NULL
and	NULL
the	NULL
results	NULL
shown	NULL
are	NULL
typical	NULL
.	NULL

Anti-CD40	NULL
mAb	NULL
Anti-CD40	NULL
mAb	NULL
+Cold	NULL
IRF1	NULL
probe	NULL
Anti-CD40	NULL
mAb	NULL
Medium	NULL
STAT	NULL
»	NULL
bust	NULL
proteins	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
supershift	NULL
assays	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
N-terminal	NULL
part	NULL
of	NULL
the	NULL
STAT5a	NULL
protein	NULL
consistently	NULL
caused	NULL
a	NULL
complete	NULL
supershift	NULL
of	NULL
the	NULL
signal	NULL
in	NULL
CD4O-activated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
STAT	NULL
5a	NULL
did	NULL
not	NULL
cause	NULL
a	NULL
significant	NULL
supershift	NULL
in	NULL
CD4O-activated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
but	NULL
did	NULL
induce	NULL
a	NULL
dramatic	NULL
supershift	NULL
in	NULL
the	NULL
IL-2-activated	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
an	NULL
actual	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
STAT	NULL
5a	NULL
molecule	NULL
,	NULL
deleted	NULL
of	NULL
the	NULL
C-terminus	NULL
part	NULL
,	NULL
is	NULL
translocated	NULL
and	NULL
activated	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
CD4O-activated	NULL
monocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
STAT	NULL
activation	NULL
was	NULL
detected	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
after	NULL
CD40	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
length	NULL
of	NULL
the	NULL
stimulation	NULL
period	NULL
(	NULL
30-180	NULL
min	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
activated	NULL
in	NULL
these	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
induced	NULL
STAT	NULL
binding	NULL
activity	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

STAT	NULL
5a	NULL
was	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
STAT5a	NULL
molecule	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Monocytes	NULL
791	NULL
Resting	NULL
B	NULL
cells	NULL
©	NULL
E=	NULL
]	NULL
2	NULL
a	NULL
a	NULL
a	NULL
<	NULL
_	NULL
<	NULL
a	NULL
E	NULL
6	NULL
E	NULL
5	NULL
0	NULL
9	NULL
2	NULL
o	NULL
£	NULL
&	NULL
g	NULL
pes	NULL
g	NULL
g	NULL
Aa	NULL
5	NULL
3	NULL
3	NULL
9	NULL
.~	NULL
c	NULL
3	NULL
9	NULL
2	NULL
0	NULL
0	NULL
=	NULL
Got	NULL
U	NULL
T	NULL
i	NULL
0	NULL
C	NULL
®	NULL
0	NULL
G	NULL
s	NULL
B	NULL
S	NULL
&	NULL
5	NULL
i	NULL
s=	NULL
4	NULL
5	NULL
¥	NULL
#	NULL
4	NULL
o	NULL
STAT	NULL
-	NULL
»	NULL
Sark	NULL
®	NULL
-	NULL
»	NULL
{	NULL
b	NULL
toll	NULL
is	NULL
f	NULL
NF-kB	NULL
_	NULL
,	NULL
.	NULL

i	NULL
43	NULL
Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
biochemical	NULL
events	NULL
induced	NULL
by	NULL
CD40	NULL
ligation	NULL
in	NULL
peripheral	NULL
blood-elutriated	NULL
monocytes	NULL
and	NULL
tonsillar	NULL
resting	NULL
B	NULL
cells	NULL
isolated	NULL
from	NULL
normal	NULL
subjects	NULL
.	NULL

The	NULL
means	NULL
of	NULL
isolation	NULL
used	NULL
gave	NULL
preparations	NULL
of	NULL
highly	NULL
purified	NULL
cells	NULL
,	NULL
with	NULL
<	NULL
5	NULL
%	NULL
contaminating	NULL
cells	NULL
.	NULL

We	NULL
obtained	NULL
evidence	NULL
that	NULL
CD40	NULL
cross-link	NULL
ing	NULL
activated	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
complex	NULL
,	NULL
but	NULL
not	NULL
AP-1	NULL
,	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
nothing	NULL
has	NULL
been	NULL
published	NULL
previously	NULL
about	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
CD4O0-stimulated	NULL
monocytes	NULL
,	NULL
whereas	NULL
conflicting	NULL
reports	NULL
have	NULL
been	NULL
published	NULL
for	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
source	NULL
of	NULL
B	NULL
lymphocytes	NULL
used	NULL
probably	NULL
accounts	NULL
for	NULL
the	NULL
observed	NULL
differences	NULL
.	NULL

Berberich	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
reported	NULL
that	NULL
CD40	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
that	NULL
NF-KB	NULL
is	NULL
induced	NULL
only	NULL
in	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
own	NULL
obser-vations	NULL
.	NULL

However	NULL
,	NULL
in	NULL
another	NULL
report	NULL
,	NULL
no	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
Activation	NULL
with	NULL
Anti-CD40	NULL
mAb	NULL
and	NULL
supershift	NULL
with	NULL
k	NULL
£	NULL
O	NULL
wunvgw§	NULL
i-€	NULL
5555555	NULL
A	NULL
i	NULL
,	NULL
2	NULL
¢	NULL
g	NULL
g	NULL
g	NULL
g	NULL
?	NULL

3	NULL
2	NULL
3	NULL
€	NULL
&	NULL
t	NULL
2	NULL
G	NULL
B	NULL
$	NULL
|	NULL
&	NULL
&	NULL
&	NULL
&	NULL
i	NULL
&	NULL
$	NULL
loca	NULL
|	NULL
__	NULL
``	NULL
e	NULL
``	NULL
$	NULL
147	NULL
-	NULL
»	NULL
Medium	NULL
B-EBV	NULL
a	NULL
s	NULL
$	NULL
1.2	NULL
F	NULL
E	NULL
o	NULL
t4	NULL
G8	NULL
£5	NULL
o	NULL
€	NULL
Ex	NULL
ER	NULL
oB	NULL
5	NULL
9	NULL
s	NULL
ga	NULL
of	NULL
94	NULL
't	NULL
14	NULL
o	NULL
Tm	NULL
TF	NULL
oF	NULL
5	NULL
aA	NULL
o	NULL
oo	NULL
aw	NULL
i	NULL
3	NULL
O	NULL
0	NULL
Ko	NULL
9	NULL
®	NULL
Lor	NULL
.29~	NULL
b	NULL
o	NULL
r	NULL
1	NULL
2	NULL
9	NULL
28	NULL
E€	NULL
$	NULL
5	NULL
Co	NULL
§	NULL
S	NULL
B	NULL
<	NULL
f	NULL
L	NULL
§	NULL
s	NULL
sf	NULL
®	NULL
4	NULL
a	NULL
gm	NULL
3	NULL
ge	NULL
tt	NULL
~*~	NULL
STAT5a	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
STATS5a	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
ligation	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Supershift	NULL
assay	NULL
with	NULL
specific	NULL
Abs	NULL
directed	NULL
against	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
STAT6	NULL
,	NULL
and	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
STAT5a	NULL
added	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
CD4O-activated	NULL
monocytes	NULL
during	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

The	NULL
different	NULL
effects	NULL
of	NULL
the	NULL
Abs	NULL
directed	NULL
against	NULL
the	NULL
C-terminal	NULL
and	NULL
the	NULL
N-terminal	NULL
parts	NULL
of	NULL
STATS5a	NULL
are	NULL
shown	NULL
in	NULL
B	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
supershift	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Ab	NULL
against	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
STAT5a	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
an	NULL
IL-2-stimulated	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
C	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
792	NULL
COMPARISON	NULL
OF	NULL
CD40	NULL
PATHWAY	NULL
IN	NULL
HUMAN	NULL
MONOCYTES	NULL
AND	NULL
B	NULL
CELLS	NULL
was	NULL
detected	NULL
in	NULL
CD4O-activated	NULL
B	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
(	NULL
56	NULL
)	NULL
.	NULL

We	NULL
provide	NULL
evidence	NULL
herein	NULL
that	NULL
the	NULL
CD4O-induced	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
were	NULL
not	NULL
identical	NULL
in	NULL
CD4O-activated	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
because	NULL
the	NULL
p65	NULL
component	NULL
was	NULL
present	NULL
only	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
p50	NULL
was	NULL
present	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
of	NULL
nuclei	NULL
from	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

Further	NULL
work	NULL
is	NULL
required	NULL
to	NULL
fully	NULL
characterize	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
detected	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
CD4O-activated	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Jak3	NULL
tyrosine	NULL
kinase	NULL
in	NULL
CD40	NULL
activation	NULL
.	NULL

We	NULL
used	NULL
an	NULL
immunoprecipitation	NULL
study	NULL
to	NULL
demonstrate	NULL
an	NULL
association	NULL
between	NULL
CD40	NULL
molecules	NULL
and	NULL
Jak3	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Such	NULL
an	NULL
association	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
by	NULL
Hanissian	NULL
and	NULL
Geha	NULL
(	NULL
46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
clearly	NULL
show	NULL
that	NULL
Jak3	NULL
was	NULL
phosphorylated	NULL
after	NULL
CD40	NULL
triggering	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

As	NULL
Jak3	NULL
activates	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
a	NULL
consensus	NULL
probe	NULL
for	NULL
STAT	NULL
proteins	NULL
.	NULL

Using	NULL
a	NULL
labeled	NULL
GRR	NULL
probe	NULL
,	NULL
STAT	NULL
DNA-binding	NULL
activity	NULL
was	NULL
consistently	NULL
detected	NULL
in	NULL
CD4O-stimulated	NULL
monocyte	NULL
nuclear	NULL
extracts	NULL
but	NULL
not	NULL
in	NULL
CD4O-activated	NULL
resting	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Supershift	NULL
assays	NULL
with	NULL
specific	NULL
Abs	NULL
showed	NULL
that	NULL
only	NULL
STAT	NULL
5a	NULL
was	NULL
induced	NULL
by	NULL
CD40	NULL
activation	NULL
in	NULL
monocytes	NULL
.	NULL

CD4O-triggered	NULL
Jak3	NULL
phosphorylation	NULL
and	NULL
STAT	NULL
translocation	NULL
,	NULL
not	NULL
studied	NULL
previously	NULL
in	NULL
monocytes	NULL
,	NULL
have	NULL
been	NULL
studied	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

Hanissian	NULL
and	NULL
Geha	NULL
described	NULL
the	NULL
induction	NULL
of	NULL
Jak3	NULL
phosphorylation	NULL
and	NULL
STAT3	NULL
translocation	NULL
(	NULL
but	NULL
no	NULL
DNA-binding	NULL
activity	NULL
analysis	NULL
of	NULL
STAT	NULL
's	NULL
was	NULL
per-formed	NULL
)	NULL
following	NULL
CD40	NULL
activation	NULL
in	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Karras	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
that	NULL
CD40	NULL
triggering	NULL
of	NULL
unsepa-rated	NULL
murine	NULL
spleen	NULL
B	NULL
cells	NULL
led	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
STAT6	NULL
,	NULL
but	NULL
not	NULL
STAT3	NULL
,	NULL
and	NULL
that	NULL
Jak3	NULL
tyrosine	NULL
kinase	NULL
was	NULL
not	NULL
phosphorylated	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
strongly	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
various	NULL
CD40-induced	NULL
biochemical	NULL
pathways	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
according	NULL
to	NULL
source	NULL
and	NULL
activation	NULL
status	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
also	NULL
found	NULL
that	NULL
CD40	NULL
activation	NULL
induced	NULL
a	NULL
peculiar	NULL
form	NULL
of	NULL
STATS5a	NULL
in	NULL
monocyte	NULL
nuclei	NULL
.	NULL

In	NULL
the	NULL
supershift	NULL
assay	NULL
,	NULL
the	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
STAT	NULL
5a	NULL
protein	NULL
did	NULL
not	NULL
recognize	NULL
any	NULL
STAT	NULL
5a	NULL
molecule	NULL
,	NULL
whereas	NULL
the	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
N-terminal	NULL
part	NULL
of	NULL
the	NULL
protein	NULL
did	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
that	NULL
CD40	NULL
ligation	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
STAT5a	NULL
.	NULL

This	NULL
truncated	NULL
form	NULL
of	NULL
STAT5a	NULL
may	NULL
be	NULL
a	NULL
degradation	NULL
product	NULL
despite	NULL
the	NULL
use	NULL
of	NULL
protease	NULL
inhibitors	NULL
or	NULL
it	NULL
may	NULL
be	NULL
a	NULL
monocyte-specific	NULL
isoform	NULL
.	NULL

Similar	NULL
monocytic	NULL
truncated	NULL
isoforms	NULL
of	NULL
STAT	NULL
5a	NULL
have	NULL
been	NULL
described	NULL
in	NULL
primary	NULL
monocytes	NULL
(	NULL
57	NULL
)	NULL
and	NULL
in	NULL
monocyte	NULL
lines	NULL
(	NULL
58	NULL
)	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
data	NULL
from	NULL
our	NULL
study	NULL
are	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
patterns	NULL
of	NULL
CD40	NULL
activation	NULL
in	NULL
monocytes	NULL
and	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

CD40	NULL
triggering	NULL
activates	NULL
Jak3	NULL
and	NULL
induces	NULL
STAT	NULL
5a	NULL
activation	NULL
in	NULL
monocytes	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
underlying	NULL
mechanism	NULL
is	NULL
unknown	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
CD40	NULL
present	NULL
on	NULL
the	NULL
membranes	NULL
of	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
are	NULL
similar	NULL
.	NULL

Jak3	NULL
appears	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
CD40	NULL
molecules	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
and	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
in	NULL
both	NULL
cell	NULL
populations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD40	NULL
activation	NULL
is	NULL
known	NULL
to	NULL
increase	NULL
the	NULL
intracellular	NULL
concentration	NULL
of	NULL
Jak3	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Cell	NULL
activation	NULL
status	NULL
may	NULL
affect	NULL
the	NULL
pattern	NULL
of	NULL
responses	NULL
to	NULL
CD40	NULL
stimulation	NULL
.	NULL

CD40	NULL
activation	NULL
of	NULL
B	NULL
cell	NULL
lines	NULL
results	NULL
in	NULL
a	NULL
pattern	NULL
of	NULL
Jak3	NULL
phosphorylation	NULL
(	NULL
46	NULL
)	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
we	NULL
describe	NULL
here	NULL
in	NULL
monocytes	NULL
.	NULL

However	NULL
,	NULL
STAT5a	NULL
is	NULL
induced	NULL
in	NULL
monocytes	NULL
,	NULL
rather	NULL
than	NULL
STAT3	NULL
,	NULL
the	NULL
translocation	NULL
of	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
Jak3	NULL
phosphorylation	NULL
in	NULL
CD4O-activated	NULL
B	NULL
cells	NULL
may	NULL
be	NULL
balanced	NULL
by	NULL
the	NULL
need	NULL
for	NULL
a	NULL
second	NULL
signal	NULL
.	NULL

This	NULL
second	NULL
signal	NULL
involves	NULL
cytokines	NULL
(	NULL
IL-4	NULL
or	NULL
IL-13	NULL
)	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
Jak	NULL
kinases	NULL
and	NULL
induce	NULL
STAT	NULL
proteins	NULL
(	NULL
54	NULL
,	NULL
60	NULL
,	NULL
61	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
regulatory	NULL
molecules	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
CD40	NULL
activation	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
.	NULL

Factors	NULL
,	NULL
especially	NULL
those	NULL
of	NULL
the	NULL
TRAF	NULL
fam-	NULL
ily	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
CD40	NULL
molecules	NULL
(	NULL
40-44	NULL
)	NULL
.	NULL

Large	NULL
amounts	NULL
of	NULL
TRAF3	NULL
are	NULL
present	NULL
in	NULL
monocytes	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
this	NULL
factor	NULL
is	NULL
hardly	NULL
detectable	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
(	NULL
62	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
TRAF3	NULL
could	NULL
be	NULL
a	NULL
good	NULL
candidate	NULL
for	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
CD40	NULL
activation	NULL
in	NULL
monocytes	NULL
;	NULL
CD40	NULL
triggering	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
Jak3	NULL
kinase	NULL
and	NULL
STAT	NULL
protein	NULL
in	NULL
TRAF3	NULL
*	NULL
cells	NULL
(	NULL
monocytes	NULL
or	NULL
activated	NULL
B	NULL
cells	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
TRAF3	NULL
_-	NULL
resting	NULL
B	NULL
cells	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
was	NULL
induced	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
activated	NULL
by	NULL
CD40	NULL
alone	NULL
is	NULL
not	NULL
inconsistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
because	NULL
B	NULL
cells	NULL
do	NULL
not	NULL
require	NULL
TRAF3	NULL
to	NULL
induce	NULL
NF-KB	NULL
after	NULL
CD40	NULL
stimulation	NULL
(	NULL
63	NULL
)	NULL
.	NULL

However	NULL
,	NULL
data	NULL
from	NULL
preliminary	NULL
experiments	NULL
indicate	NULL
that	NULL
a	NULL
24-h	NULL
preincubation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
induces	NULL
TRAF3	NULL
expression	NULL
,	NULL
but	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
Jak3/STAT	NULL
pathway	NULL
by	NULL
CD40	NULL
agonists	NULL
does	NULL
not	NULL
occur	NULL
.	NULL

Thus	NULL
,	NULL
other	NULL
regulatory	NULL
molecules	NULL
,	NULL
belonging	NULL
to	NULL
the	NULL
TRAF	NULL
family	NULL
or	NULL
interacting	NULL
with	NULL
TRAF	NULL
factors	NULL
,	NULL
are	NULL
probably	NULL
involved	NULL
.	NULL

The	NULL
different	NULL
patterns	NULL
of	NULL
CD40	NULL
activation	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
observed	NULL
in	NULL
this	NULL
study	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
clinical	NULL
features	NULL
of	NULL
patients	NULL
suffering	NULL
from	NULL
CD4O0L	NULL
*	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
(	NULL
33-35	NULL
)	NULL
.	NULL

These	NULL
patients	NULL
suffer	NULL
from	NULL
Ig	NULL
switch	NULL
defect	NULL
but	NULL
are	NULL
not	NULL
susceptible	NULL
to	NULL
intracellular	NULL
pathogens	NULL
.	NULL

In	NULL
these	NULL
patients	NULL
,	NULL
the	NULL
normal	NULL
CD40	NULL
activation	NULL
of	NULL
monocyte/dendritic	NULL
cells	NULL
contrasting	NULL
with	NULL
the	NULL
complete	NULL
lack	NULL
of	NULL
CD40	NULL
response	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
36	NULL
)	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
existence	NULL
of	NULL
different	NULL
CD40	NULL
activation	NULL
pathways	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
B.	NULL
Groner	NULL
(	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
Tumor	NULL
Biology	NULL
Center	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
the	NULL
Ab	NULL
directed	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
STAT5a	NULL
and	NULL
Dr.	NULL
R.	NULL
Weil	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
the	NULL
anti-p50	NULL
Ab	NULL
.	NULL

We	NULL
thank	NULL
Dr	NULL
.	NULL

I.	NULL
Dusanter-Fourt	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Prof.	NULL
E.	NULL
N.	NULL
Garabedian	NULL
,	NULL
M.	NULL
Dallet	NULL
,	NULL
and	NULL
all	NULL
the	NULL
staff	NULL
(	NULL
Hopital	NULL
Trousseau	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
human	NULL
tonsils	NULL
.	NULL

We	NULL
thank	NULL
M.	NULL
For-veille	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
F.	NULL
Geissmann	NULL
,	NULL
S.	NULL
Jauliac	NULL
,	NULL
Y.	NULL
Zermati	NULL
,	NULL
and	NULL
F.	NULL
Mazerolles	NULL
for	NULL
advice	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
mediated	NULL
through	NULL
two	NULL
distinct	NULL
cell	NULL
surface	NULL
differentiation	NULL
antigens	NULL
,	NULL
Bp35	NULL
and	NULL
Bp50	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:4494	NULL
.	NULL

2	NULL
.	NULL

Paulie	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
B.	NULL
Ehlin	NULL
,	NULL
H.	NULL
Mellstedt	NULL
,	NULL
H.	NULL
Koho	NULL
,	NULL
A.	NULL
H.	NULL
Ben	NULL
,	NULL
and	NULL
P.	NULL
Perlmann	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
p50	NULL
surface	NULL
antigen	NULL
restricted	NULL
to	NULL
human	NULL
urinary	NULL
bladder	NULL
carcinomas	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

Cancer	NULL
Immunol	NULL
.	NULL

Immunother	NULL
.	NULL

20:23	NULL
.	NULL

3	NULL
.	NULL

Hart	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
McKenzie	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
tonsil	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:157	NULL
.	NULL

4	NULL
.	NULL

Galy	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1992	NULL
.	NULL

CD40	NULL
is	NULL
functionally	NULL
expressed	NULL
on	NULL
human	NULL
thymic	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:775	NULL
.	NULL

5	NULL
.	NULL

Jumper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Splawski	NULL
,	NULL
P.	NULL
E.	NULL
Lipsky	NULL
,	NULL
and	NULL
K.	NULL
Meck	NULL
.	NULL

1994	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
induces	NULL
sterile	NULL
transcripts	NULL
of	NULL
multiple	NULL
Ig	NULL
chain	NULL
isotypes	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:438	NULL
.	NULL

6	NULL
.	NULL

Zhang	NULL
,	NULL
K.	NULL
,	NULL
E.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
A.	NULL
Saxon	NULL
.	NULL

1991	NULL
.	NULL

CD40	NULL
stimulation	NULL
provides	NULL
an	NULL
IFN-y-independent	NULL
and	NULL
IL-4-dependent	NULL
differentiation	NULL
signal	NULL
directly	NULL
to	NULL
human	NULL
B	NULL
cells	NULL
for	NULL
IgE	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1836	NULL
.	NULL

7	NULL
.	NULL

Rousset	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
Garcia	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1991	NULL
.	NULL

Cytokine-induced	NULL
proliferation	NULL
and	NULL
immunoglobulin	NULL
production	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
triggered	NULL
through	NULL
their	NULL
CD40	NULL
antigen	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:705	NULL
.	NULL

8	NULL
.	NULL

Shapira	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
D.	NULL
Vercelli	NULL
,	NULL
H.	NULL
H.	NULL
Jabara	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
immunoglobulin	NULL
E	NULL
synthesis	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
interleukin	NULL
4	NULL
and	NULL
engagement	NULL
of	NULL
the	NULL
CD40	NULL
antigen	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:289	NULL
.	NULL

9	NULL
.	NULL

Spriggs	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
R.	NULL
J.	NULL
Armitage	NULL
,	NULL
L.	NULL
Strockbine	NULL
,	NULL
K.	NULL
N.	NULL
Clifford	NULL
,	NULL
B.	NULL
M.	NULL
Macduff	NULL
,	NULL
T.	NULL
A.	NULL
Sato	NULL
,	NULL
C.	NULL
R.	NULL
Maliszewski	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Fanslow	NULL
.	NULL

1992	NULL
.	NULL

Recombinant	NULL
human	NULL
CD40	NULL
ligand	NULL
stimulates	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
immunoglobulin	NULL
E	NULL
secretion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1543	NULL
.	NULL

10	NULL
.	NULL

Brigre	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Servet-Delprat	NULL
,	NULL
J.	NULL
M.	NULL
Bridon	NULL
,	NULL
J.	NULL
M.	NULL
Saint-Remy	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
interleukin	NULL
10	NULL
induces	NULL
naive	NULL
surface	NULL
immunoglobulin	NULL
D*	NULL
(	NULL
sIgD*	NULL
)	NULL
B	NULL
cells	NULL
to	NULL
secrete	NULL
IgG1	NULL
and	NULL
IgG3	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:757	NULL
.	NULL

11	NULL
.	NULL

Lane	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Traunecker	NULL
,	NULL
S.	NULL
Hubele	NULL
,	NULL
S.	NULL
Inui	NULL
,	NULL
A.	NULL
Lanzavecchia	NULL
,	NULL
and	NULL
D.	NULL
Gray	NULL
.	NULL

1992	NULL
.	NULL

Activated	NULL
human	NULL
T	NULL
cells	NULL
express	NULL
a	NULL
ligand	NULL
for	NULL
the	NULL
human	NULL
B	NULL
cell-associated	NULL
antigen	NULL
CD40	NULL
,	NULL
which	NULL
participates	NULL
in	NULL
T	NULL
cell-dependent	NULL
activation	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:2573	NULL
.	NULL

12	NULL
.	NULL

Hollenbaugh	NULL
,	NULL
D.	NULL
,	NULL
L.	NULL
Grosmaire	NULL
,	NULL
D.	NULL
Kullas	NULL
,	NULL
N.	NULL
J.	NULL
Chalupny	NULL
,	NULL
R.	NULL
J.	NULL
Noelle	NULL
,	NULL
I.	NULL
Stamenkovic	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
A.	NULL
Aruffo	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
antigen	NULL
gp39	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
,	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
the	NULL
CD40	NULL
receptor	NULL
:	NULL
expression	NULL
of	NULL
a	NULL
soluble	NULL
form	NULL
of	NULL
gp39	NULL
with	NULL
B	NULL
cell	NULL
co-stimulating	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4313	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Lederman	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
J.	NULL
Yellin	NULL
,	NULL
G.	NULL
Inghirani	NULL
,	NULL
J.	NULL
L.	NULL
Lee	NULL
,	NULL
D.	NULL
M.	NULL
Knowles	NULL
,	NULL
and	NULL
L.	NULL
Chess	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
interactions	NULL
mediating	NULL
T-B	NULL
lymphocyte	NULL
collaboration	NULL
in	NULL
human	NULL
lymphoid	NULL
follicles	NULL
:	NULL
role	NULL
of	NULL
T	NULL
cell-B	NULL
cell	NULL
activity	NULL
molecule	NULL
(	NULL
5c8	NULL
antigen	NULL
)	NULL
and	NULL
CD40	NULL
in	NULL
contact-dependent	NULL
help	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3817	NULL
.	NULL

Holder	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
H.	NULL
Wang	NULL
,	NULL
A.	NULL
E.	NULL
M.	NULL
Casamayor	NULL
,	NULL
R.	NULL
Armitage	NULL
,	NULL
M.	NULL
K.	NULL
Spriggs	NULL
,	NULL
W.	NULL
C.	NULL
Fanslow	NULL
,	NULL
I.	NULL
C.	NULL
M.	NULL
MacLennan	NULL
,	NULL
C.	NULL
D.	NULL
Gregory	NULL
,	NULL
and	NULL
J.	NULL
Gordon	NULL
.	NULL

1993	NULL
.	NULL

Suppression	NULL
of	NULL
apoptosis	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
human	NULL
B	NULL
lymphocyte	NULL
by	NULL
CD40	NULL
is	NULL
independent	NULL
of	NULL
bel2	NULL
induction	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:2368	NULL
.	NULL

Wagner	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
J.	NULL
R.	NULL
D.	NULL
Stout	NULL
,	NULL
and	NULL
J.	NULL
Suttles	NULL
.	NULL

1994	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
€D40-CD40	NULL
ligand	NULL
interaction	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
contact-dependent	NULL
activation	NULL
of	NULL
monocyte	NULL
in-terleukin-1	NULL
synthesis	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:3148	NULL
.	NULL

Alderson	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
J.	NULL
Armitage	NULL
,	NULL
T.	NULL
W.	NULL
Tough	NULL
,	NULL
L.	NULL
Strockbine	NULL
,	NULL
W.	NULL
C.	NULL
Fanslow	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Spriggs	NULL
.	NULL

1993	NULL
.	NULL

CD40	NULL
expression	NULL
by	NULL
human	NULL
monocytes	NULL
:	NULL
regulation	NULL
by	NULL
cytokines	NULL
and	NULL
activation	NULL
of	NULL
monocytes	NULL
by	NULL
the	NULL
ligand	NULL
for	NULL
CD40	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:669	NULL
.	NULL

Kiener	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
P.	NULL
Moran-Davis	NULL
,	NULL
B.	NULL
M.	NULL
Rankin	NULL
,	NULL
A.	NULL
F.	NULL
Wahl	NULL
,	NULL
A.	NULL
Ajuffo	NULL
,	NULL
and	NULL
D.	NULL
Hollenbaugh	NULL
.	NULL

1995	NULL
.	NULL

Stimulation	NULL
of	NULL
CD40	NULL
with	NULL
purified	NULL
soluble	NULL
gp39	NULL
induces	NULL
proinflammatory	NULL
responses	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4917	NULL
.	NULL

Suttles	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Evans	NULL
,	NULL
R.	NULL
W.	NULL
Miller	NULL
,	NULL
J.	NULL
C.	NULL
Poe	NULL
,	NULL
R.	NULL
D.	NULL
Stout	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Wahl	NULL
.	NULL

1996	NULL
.	NULL

T	NULL
cell	NULL
rescue	NULL
of	NULL
monocytes	NULL
from	NULL
apoptosis	NULL
:	NULL
role	NULL
of	NULL
€CD40-CD40L	NULL
interaction	NULL
and	NULL
requirement	NULL
for	NULL
CD4O0-mediated	NULL
induction	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

60:651	NULL
.	NULL

Cella	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Scheidegger	NULL
,	NULL
K.	NULL
Palmer-Lehman	NULL
,	NULL
P.	NULL
Lane	NULL
,	NULL
A.	NULL
Lanzavecchia	NULL
,	NULL
and	NULL
G.	NULL
Alber	NULL
.	NULL

1996	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
on	NULL
dendritic	NULL
cells	NULL
triggers	NULL
production	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
interleukin-12	NULL
and	NULL
enhances	NULL
T	NULL
cell	NULL
stimulatory	NULL
capacity	NULL
:	NULL
T-T	NULL
help	NULL
via	NULL
APC	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:747	NULL
.	NULL

Ridge	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
F.	NULL
DiRosa	NULL
,	NULL
and	NULL
P.	NULL
Matzinger	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
conditioned	NULL
dendritic	NULL
cell	NULL
can	NULL
be	NULL
a	NULL
temporal	NULL
bridge	NULL
between	NULL
a	NULL
CD4*	NULL
T-helper	NULL
and	NULL
a	NULL
T-killer	NULL
cell	NULL
.	NULL

Nature	NULL
393:474	NULL
.	NULL

Schoenberger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
R.	NULL
E.	NULL
Toes	NULL
,	NULL
E.	NULL
I.	NULL
van	NULL
der	NULL
Voort	NULL
,	NULL
R.	NULL
Offringa	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Melief	NULL
.	NULL

1998	NULL
.	NULL

T-cell	NULL
help	NULL
for	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
is	NULL
mediated	NULL
by	NULL
CD40-CD40L	NULL
interactions	NULL
.	NULL

Nature	NULL
393:480	NULL
.	NULL

Bennett	NULL
,	NULL
S.	NULL
R.	NULL
M.	NULL
,	NULL
F.	NULL
R.	NULL
Carbone	NULL
,	NULL
F.	NULL
Karamalis	NULL
,	NULL
R.	NULL
A.	NULL
Flavell	NULL
,	NULL
J.	NULL
F.	NULL
A.	NULL
P.	NULL
Miller	NULL
,	NULL
and	NULL
W.	NULL
R.	NULL
Heath	NULL
.	NULL

1998	NULL
.	NULL

Help	NULL
for	NULL
cytotoxic-T-cell	NULL
responses	NULL
is	NULL
mediated	NULL
by	NULL
CD40	NULL
signaling	NULL
.	NULL

Nature	NULL
393:478	NULL
.	NULL

Soong	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
C.	NULL
Xu	NULL
,	NULL
I	NULL
.	NULL

S	NULL
Grewal	NULL
,	NULL
P.	NULL
Kima	NULL
,	NULL
J	NULL
.	NULL

Sun	NULL
,	NULL
B.	NULL
J.	NULL
Longley	NULL
,	NULL
N.	NULL
H.	NULL
Ruddle	NULL
,	NULL
D.	NULL
MacMahon-Pratt	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

Disruption	NULL
of	NULL
€D40-CD40	NULL
ligand	NULL
interactions	NULL
results	NULL
in	NULL
an	NULL
enhanced	NULL
susceptibility	NULL
to	NULL
Leishmania	NULL
amazonensis	NULL
in-fection	NULL
.	NULL

Immunity	NULL
4:263	NULL
.	NULL

Kamanaka	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Yu	NULL
,	NULL
T.	NULL
Yasui	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kawabe	NULL
,	NULL
T.	NULL
Horii	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
H.	NULL
Kikutani	NULL
.	NULL

1996	NULL
.	NULL

Protective	NULL
role	NULL
of	NULL
CD40	NULL
in	NULL
Leishmania	NULL
major	NULL
infection	NULL
at	NULL
two	NULL
distinct	NULL
phases	NULL
of	NULL
cell-mediated	NULL
immunity	NULL
.	NULL

Immunity	NULL
4:275	NULL
.	NULL

Campbell	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
P.	NULL
J.	NULL
Ovendale	NULL
,	NULL
M.	NULL
K.	NULL
Kennedy	NULL
,	NULL
W.	NULL
C.	NULL
Fanslow	NULL
,	NULL
S.	NULL
G	NULL
,	NULL
Reed	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Maliszewski	NULL
.	NULL

1996	NULL
.	NULL

CD40	NULL
ligand	NULL
is	NULL
required	NULL
for	NULL
protective	NULL
cell-mediated	NULL
immunity	NULL
to	NULL
Leishmania	NULL
major	NULL
.	NULL

Immunity	NULL
4:283	NULL
.	NULL

Xu	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
M.	NULL
Foy	NULL
,	NULL
J.	NULL
D.	NULL
Laman	NULL
,	NULL
E.	NULL
A.	NULL
Elliott	NULL
,	NULL
J.	NULL
J.	NULL
Dunn	NULL
,	NULL
T.	NULL
J.	NULL
Waldschmidt	NULL
,	NULL
J.	NULL
Elsemore	NULL
,	NULL
R.	NULL
J.	NULL
Noelle	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
the	NULL
CD40	NULL
ligand	NULL
.	NULL

Immunity	NULL
1:423	NULL
.	NULL

Kawabe	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Naka	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
H.	NULL
Kikutani	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
immune	NULL
responses	NULL
in	NULL
CD4O-deficient	NULL
mice	NULL
:	NULL
impaired	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
and	NULL
germinal	NULL
formation	NULL
.	NULL

Immunity	NULL
1:167	NULL
.	NULL

Allen	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
R.	NULL
J.	NULL
Armitage	NULL
,	NULL
M.	NULL
E.	NULL
Conley	NULL
,	NULL
H.	NULL
Rosenblatt	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
M.	NULL
A.	NULL
Bedell	NULL
,	NULL
S.	NULL
Edelhoff	NULL
,	NULL
C.	NULL
M.	NULL
Disteche	NULL
,	NULL
D.	NULL
K.	NULL
Simoneaux	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

CD40	NULL
ligand	NULL
gene	NULL
defects	NULL
responsible	NULL
for	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
.	NULL

Science	NULL
259:990	NULL
.	NULL

Aruffo	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Farrington	NULL
,	NULL
D.	NULL
Hollenbaugh	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
A.	NULL
Milatovitch	NULL
,	NULL
S.	NULL
Nonoyama	NULL
,	NULL
J.	NULL
Bajorath	NULL
,	NULL
L.	NULL
S.	NULL
Grosmaire	NULL
,	NULL
R.	NULL
Stenkamp	NULL
,	NULL
M.	NULL
Neubauer	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
CD40	NULL
ligand	NULL
,	NULL
gp39	NULL
,	NULL
is	NULL
defective	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
.	NULL

Cell	NULL
72:291	NULL
.	NULL

Korthauer	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Graf	NULL
,	NULL
H.	NULL
W.	NULL
Mages	NULL
,	NULL
F.	NULL
Brigre	NULL
,	NULL
M.	NULL
Padayachee	NULL
,	NULL
S.	NULL
Malcolm	NULL
,	NULL
A.	NULL
G.	NULL
Ugazio	NULL
,	NULL
L.	NULL
D.	NULL
Notarangelo	NULL
,	NULL
R.	NULL
J.	NULL
Levinsky	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Kroczek	NULL
.	NULL

1993	NULL
.	NULL

Defective	NULL
expression	NULL
of	NULL
T-cell	NULL
CD40	NULL
ligand	NULL
causes	NULL
X-linked	NULL
immunodeficiency	NULL
with	NULL
hyper-IgM	NULL
.	NULL

Nature	NULL
361:359	NULL
.	NULL

DiSanto	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
A.	NULL
Fischer	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
Saint	NULL
Basile	NULL
.	NULL

1993	NULL
.	NULL

CD40	NULL
ligand	NULL
mutations	NULL
in	NULL
X-linked	NULL
immunodeficiency	NULL
with	NULL
hyper-IgM	NULL
.	NULL

Nature	NULL
361:541	NULL
.	NULL

Fuleiban	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Ramesh	NULL
,	NULL
R.	NULL
Loh	NULL
,	NULL
H.	NULL
Jabara	NULL
,	NULL
F.	NULL
S.	NULL
Rosen	NULL
,	NULL
T.	NULL
Chatila	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
I.	NULL
Stamenkovic	NULL
,	NULL
and	NULL
R.	NULL
Geha	NULL
.	NULL

1993	NULL
.	NULL

Defective	NULL
expression	NULL
of	NULL
the	NULL
CD40	NULL
ligand	NULL
in	NULL
X	NULL
chromosome-linked	NULL
immunoglobulin	NULL
deficiency	NULL
with	NULL
normal	NULL
or	NULL
elevated	NULL
IgM	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2170	NULL
.	NULL

Durandy	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Hivroz	NULL
,	NULL
F.	NULL
Mazerolles	NULL
,	NULL
C.	NULL
Schiff	NULL
,	NULL
F.	NULL
Bernard	NULL
,	NULL
E.	NULL
Jouanguy	NULL
,	NULL
P.	NULL
Revy	NULL
,	NULL
J.	NULL
P.	NULL
DiSanto	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Abnormal	NULL
CD4O-mediated	NULL
activation	NULL
pathway	NULL
in	NULL
B	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
and	NULL
normal	NULL
CD4O-ligand	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2576	NULL
.	NULL

Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
M.	NULL
Larch	NULL
.	NULL

V.	NULL
R.	NULL
Bonagura	NULL
,	NULL
A.	NULL
R.	NULL
Lawton	NULL
III	NULL
,	NULL
R.	NULL
H.	NULL
Buckley	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
E.	NULL
Coustan-Smith	NULL
,	NULL
H.	NULL
G.	NULL
Herrod	NULL
,	NULL
and	NULL
D.	NULL
Campana	NULL
.	NULL

1994	NULL
.	NULL

Hyper	NULL
IgM	NULL
syndrome	NULL
associated	NULL
with	NULL
defective	NULL
CD4O-mediated	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:1404	NULL
.	NULL

Callard	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
S.	NULL
H.	NULL
Smith	NULL
,	NULL
J.	NULL
Herbert	NULL
,	NULL
G.	NULL
Morgan	NULL
,	NULL
M.	NULL
Padayachee	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
L.	NULL
Chess	NULL
,	NULL
R.	NULL
A.	NULL
Kroczek	NULL
,	NULL
W.	NULL
C.	NULL
Fanslow	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Armitage	NULL
.	NULL

1994	NULL
.	NULL

CD40	NULL
ligand	NULL
(	NULL
CD4OL	NULL
)	NULL
expression	NULL
and	NULL
B	NULL
cell	NULL
function	NULL
in	NULL
agammaglobulinemia	NULL
with	NULL
normal	NULL
or	NULL
elevated	NULL
levels	NULL
of	NULL
IgM	NULL
(	NULL
HIM	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:3295	NULL
.	NULL

Revy	NULL
,	NULL
P.	NULL
,	NULL
F.	NULL
Geissmann	NULL
,	NULL
M.	NULL
Debré	NULL
,	NULL
A.	NULL
Fischer	NULL
,	NULL
and	NULL
A.	NULL
Durandy	NULL
.	NULL

1998	NULL
.	NULL

Normal	NULL
CD4O-mediated	NULL
activation	NULL
of	NULL
monocytes	NULL
and	NULL
dendritic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
hyper	NULL
IgM	NULL
syndrome	NULL
due	NULL
to	NULL
a	NULL
CD40	NULL
pathway	NULL
defect	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:3648	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

793	NULL
Ren	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
T.	NULL
Morio	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
via	NULL
CD40	NULL
involves	NULL
activation	NULL
of	NULL
lyn	NULL
kinase	NULL
and	NULL
phosphatidylinositol-3-kinase	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
Cy2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:673	NULL
.	NULL

Francis	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Karras	NULL
,	NULL
X.	NULL
Y.	NULL
Ke	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-AT	NULL
during	NULL
B	NULL
cell	NULL
stimulation	NULL
through	NULL
the	NULL
CD40	NULL
receptor	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:151	NULL
.	NULL

Berberich	NULL
,	NULL
I.	NULL
,	NULL
G.	NULL
L.	NULL
Shu	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clark	NULL
.	NULL

1994	NULL
.	NULL

Cross-linking	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
rapidly	NULL
activates	NULL
NF-KB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4357	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF-mediated	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424	NULL
.	NULL

Hu	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
M.	NULL
S.	NULL
Boguski	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
RING	NULL
finger	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30069	NULL
.	NULL

Sato	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Irie	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Reed	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TRAF	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducing	NULL
proteins	NULL
binds	NULL
to	NULL
the	NULL
cytosolic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

358:113	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
M.	NULL
Cleary	NULL
,	NULL
Z.	NULL
S.	NULL
Ye	NULL
,	NULL
D.	NULL
I.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAF1	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267:1494.	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

TANK	NULL
,	NULL
a	NULL
co-inducer	NULL
with	NULL
TRAF2	NULL
of	NULL
TNF	NULL
and	NULL
CD40L-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:963	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Pan	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
TNFR2-TRAF	NULL
signaling	NULL
complex	NULL
contains	NULL
two	NULL
novel	NULL
proteins	NULL
related	NULL
to	NULL
baculo-viral	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
proteins	NULL
.	NULL

Cell	NULL
83:1243	NULL
.	NULL

Hanissian	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1997	NULL
.	NULL

Jak3	NULL
is	NULL
associated	NULL
with	NULL
CD40	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
CD40	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
6:379	NULL
.	NULL

Karras	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Z.	NULL
Whang	NULL
,	NULL
L.	NULL
Huo	NULL
,	NULL
D.	NULL
A.	NULL
Frank	NULL
,	NULL
and	NULL
T.	NULL
Rothstein	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
STAT	NULL
protein	NULL
signaling	NULL
through	NULL
the	NULL
CD40	NULL
receptor	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4350	NULL
.	NULL

Jabara	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
R.	NULL
H.	NULL
Buckley	NULL
,	NULL
J.	NULL
L.	NULL
Roberts	NULL
,	NULL
G.	NULL
Lefranc	NULL
,	NULL
J.	NULL
Loiselet	NULL
,	NULL
G.	NULL
Khalil	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
JAK3	NULL
in	NULL
CD4O0-mediated	NULL
signaling	NULL
.	NULL

Blood	NULL
92:2435	NULL
.	NULL

Faradji	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Bohbot	NULL
,	NULL
M.	NULL
Schmitt-Goguel	NULL
,	NULL
J.	NULL
C.	NULL
Siffert	NULL
,	NULL
S.	NULL
Dumont	NULL
,	NULL
M.	NULL
L..	NULL
Wiesel	NULL
,	NULL
Y.	NULL
Piemont	NULL
,	NULL
A.	NULL
Eischen	NULL
,	NULL
J.	NULL
P.	NULL
Bergerat	NULL
,	NULL
J.	NULL
Bartholeyns	NULL
,	NULL
P.	NULL
Paindron	NULL
,	NULL
J.	NULL
P.	NULL
Witz	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Large	NULL
scale	NULL
isolation	NULL
of	NULL
human	NULL
blood	NULL
monocytes	NULL
by	NULL
continuous	NULL
flow	NULL
centrifugation	NULL
leukapheresis	NULL
and	NULL
counterflow	NULL
centrifugation	NULL
elutriation	NULL
for	NULL
adoptive	NULL
cellular	NULL
immunotherapy	NULL
in	NULL
cancer	NULL
patients	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
174:297	NULL
.	NULL

Mazzei	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
M.	NULL
D.	NULL
Edgerton	NULL
,	NULL
C.	NULL
Losberger	NULL
,	NULL
S.	NULL
Lecoanct-Henchoz	NULL
,	NULL
P.	NULL
Graber	NULL
,	NULL
A.	NULL
Durandy	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
A.	NULL
Bernard	NULL
,	NULL
and	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
.	NULL

1995	NULL
.	NULL

Recombinant	NULL
soluble	NULL
trimeric	NULL
CD40	NULL
ligand	NULL
is	NULL
biologically	NULL
active	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:7025	NULL
.	NULL

Gouilleux	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Pallard	NULL
,	NULL
I.	NULL
Dusanter-Fourt	NULL
,	NULL
H.	NULL
Wakao	NULL
,	NULL
L.	NULL
A.	NULL
Haldosen	NULL
,	NULL
G.	NULL
Norstedt	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
and	NULL
B.	NULL
Groner	NULL
.	NULL

1995	NULL
.	NULL

Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
eryth-ropoietin	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
induce	NULL
MGF-STATS	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2005	NULL
.	NULL

Hivroz-Burgaud	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1991	NULL
.	NULL

Signaling	NULL
requirements	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transactivating	NULL
factor	NULL
NF-AT	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:2811	NULL
.	NULL

Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
W.	NULL
E.	NULL
Thierfelder	NULL
,	NULL
B.	NULL
Kreider	NULL
,	NULL
and	NULL
O.	NULL
Silvennoinen	NULL
.	NULL

1994	NULL
.	NULL

Signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
su-perfamily	NULL
:	NULL
JAKs	NULL
and	NULL
STATs	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19:222	NULL
.	NULL

Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Harpur	NULL
.	NULL

1994	NULL
.	NULL

Cytokine	NULL
signal	NULL
transduction	NULL
and	NULL
the	NULL
JAK	NULL
family	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Bioessays	NULL
16:313	NULL
.	NULL

Pelligrini	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
I.	NULL
Dusanter-Fourt	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
structure	NULL
,	NULL
regulation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Janus	NULL
Kinases	NULL
(	NULL
JAKs	NULL
)	NULL
and	NULL
the	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STATs	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

248:615	NULL
.	NULL

Jeppson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
H.	NULL
R.	NULL
Patel	NULL
,	NULL
N.	NULL
Sakata	NULL
,	NULL
J.	NULL
Domenico	NULL
,	NULL
N.	NULL
Terada	NULL
,	NULL
and	NULL
E.	NULL
W.	NULL
Gelfand	NULL
.	NULL

1998	NULL
.	NULL

Requirement	NULL
for	NULL
dual	NULL
signals	NULL
by	NULL
anti-CD40	NULL
and	NULL
IL-4	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IgE	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161	NULL
:	NULL
1738	NULL
.	NULL

Rosen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
K.	NULL
D.	NULL
Winestock	NULL
,	NULL
G.	NULL
Chen	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1996	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
preferentially	NULL
activates	NULL
the	NULL
94-kDa	NULL
STAT5A	NULL
and	NULL
an	NULL
80-kDa	NULL
STAT5A	NULL
isoform	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Blood	NULL
88:1206	NULL
.	NULL

Lokuta	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
McDowell	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Paulnock	NULL
.	NULL

1998	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
additional	NULL
isoform	NULL
of	NULL
STATS	NULL
expressed	NULL
in	NULL
immature	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1594	NULL
.	NULL

Tortolani	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
B.	NULL
K.	NULL
Lal	NULL
,	NULL
A.	NULL
Riva	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
G.	NULL
H.	NULL
Reaman	NULL
,	NULL
M.	NULL
Beckwith	NULL
,	NULL
D.	NULL
Longo	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
K.	NULL
Bhatia	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
Jak3	NULL
expression	NULL
and	NULL
activation	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
B	NULL
cell	NULL
malignancies	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:5220	NULL
.	NULL

Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
F.	NULL
Candotti	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
Y.	NULL
Chen	NULL
,	NULL
J.	NULL
J.	NULL
Ryan	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
X.	NULL
Liu	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
L.	NULL
D.	NULL
Notarangelo	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
via	NULL
IL-2	NULL
and	NULL
IL-4	NULL
in	NULL
JAK-deficient	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
lymphocytes	NULL
:	NULL
Jak3-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
.	NULL

Immunity	NULL
5:605	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
P.	NULL
J.	NULL
Tortolani	NULL
,	NULL
M.	NULL
J.	NULL
McReynolds	NULL
,	NULL
C.	NULL
Kinzer	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1995	NULL
.	NULL

Similarities	NULL
and	NULL
differences	NULL
in	NULL
signal	NULL
transduction	NULL
by	NULL
interleukin	NULL
4	NULL
and	NULL
interleukin	NULL
13	NULL
:	NULL
analysis	NULL
of	NULL
Janus	NULL
kinase	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7681	NULL
.	NULL

Krajewski	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
M.	NULL
Zapata	NULL
,	NULL
M.	NULL
Krajewska	NULL
,	NULL
T.	NULL
van	NULL
Arsdale	NULL
,	NULL
A.	NULL
Shabaik	NULL
,	NULL
R.	NULL
D.	NULL
Gascoyne	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Reed	NULL
.	NULL

1997	NULL
.	NULL

Immunchistochemical	NULL
analysis	NULL
of	NULL
in	NULL
vivo	NULL
patterns	NULL
of	NULL
TRAF-3	NULL
expression	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
family	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5841	NULL
.	NULL

Grammer	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
J.	NULL
L.	NULL
Swantek	NULL
,	NULL
R.	NULL
D.	NULL
McFarland	NULL
,	NULL
Y.	NULL
Miura	NULL
,	NULL
T.	NULL
Geppert	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1998	NULL
.	NULL

TNF	NULL
receptor-associated	NULL
factor-3	NULL
signaling	NULL
mediates	NULL
activation	NULL
of	NULL
p38	NULL
and	NULL
Jun	NULL
N-terminal	NULL
kinase	NULL
,	NULL
cytokine	NULL
secretion	NULL
,	NULL
and	NULL
Ig	NULL
production	NULL
following	NULL
ligation	NULL
of	NULL
CD40	NULL
on	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1183	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

